Home Solutions Precision Motion for Clinical Trials

Precision Motion for Clinical Trials

Get Clario's complete solution for measuring objective digital endpoints of mobility with wearable sensor technology.

Talk to a specialist

Opal V2C® System
FDA Class II Medical Device
CE Class I Medical Device

Capture digital endpoints in clinical trials, both in-clinic and at-home

Those endpoints help sponsors quantify richer insights that deliver meaningful clinical outcomes and transform patient’s lives through better evidence for gait, balance and additional mobility tests.

Opal V2C System offers movement tests across 4 core domains

01 Gait
- 2-minute walk
- 6-minute walk
- Open-ended walk
Gait Initiation and Turns are included in the 2MWT and Open-Ended Walk, Turns are included in the 6MWT
02 Balance
- Eyes open/closed
- Feet apart/together
- Firm/foam surface
- Tandem/single leg
03 Additional mobility
- Timed up and go
- Sit to stand
- 360 degree turn
- Stand and walk
04 Actigraphy and sleep

Opal V2C^® also captures Actigraphy and Sleep data – to capture valuable real-world data about your patients

Power your clinical trial with wearable sensors

Clario’s Opal V2C^®️ precision motion monitoring and actigraphy solution is validated across many indications, including Parkinson’s Disease (PD), Multiple Sclerosis (MS), Spinocerebellar Ataxia (SCA), and more.

It enables efficient data capture by:

Delivering real-time data through Precision Motion Monitoring (PerfO) of gait, balance and mobility
Having pre-configured standard assessments of instrumented tests embedded in software with more than 140 validated outcome measures
Providing analytics through our Mobility Lab software platform
Guided patient coaching through the assessment procedure

Available solutions

Precision Motion: Scientific Consulting Services

Expert guidance on generating the richest clinical evidence by capturing precise and meaningful aspects of mobility in clinical trials.

Find out more

Clario generates the richest evidence for clinical trials

For the past 10 years, more than 1,000 researchers worldwide have used Opal technology to evaluate human movement and patient functional mobility. Our Opal technology has been studied and cited in 750+ peer-reviewed scientific publications. Our expert scientific advisory team has generated a body of evidence with over 45,000 scientific citations.